با برنامه Player FM !
What's happening with specialised commissioning in the NHS?
Manage episode 400570631 series 3381584
What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?
Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in the NHS and what to expect as we head into 2024.
Malcolm Qualie and David Thorne explored:
- Specialised commissioning in the NHS
- The risks and opportunities that devolution to ICBs will bring
- What we can expect to see in the short and longer term
- How industry can support ICB leaders through this transition
- How Pharma, Medtech, and Diagnostics companies, whose products come under specialised commissioning, can manage these risks and uncertainties
Learn more at https://mtechaccess.co.uk/nhs-specialised-commissioning/
This episode first broadcast as a live webinar in Decmeber 2023.
Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
فصل ها
1. Welcome & introductions (00:00:00)
2. Changes to specialised commissioning (00:05:20)
3. Implications for industry (00:07:20)
4. Population based budgeting (00:12:20)
5. Moving money across a pathway (00:18:56)
6. Postcode prescribing: local variation vs national variation (00:27:04)
7. What should companies be doing now around specialised commissioning? (00:38:00)
8. Who to engage with: Trusts or ICBs? (00:45:12)
9. Looking to the future - what could specialised commissioning look like in 18 months time? (00:53:14)
59 قسمت
Manage episode 400570631 series 3381584
What’s happening with specialised commissioning in the NHS? How likely is a delay in delegation to integrated care boards (ICBs)? How and what should Pharma and Medtech plan for amidst all this uncertainty?
Malcolm Qualie (former Medicines Lead for Specialised Services, NHS England) speaks to David Thorne (Principal Associate, Mtech Access) to explore specialised commissioning in the NHS and what to expect as we head into 2024.
Malcolm Qualie and David Thorne explored:
- Specialised commissioning in the NHS
- The risks and opportunities that devolution to ICBs will bring
- What we can expect to see in the short and longer term
- How industry can support ICB leaders through this transition
- How Pharma, Medtech, and Diagnostics companies, whose products come under specialised commissioning, can manage these risks and uncertainties
Learn more at https://mtechaccess.co.uk/nhs-specialised-commissioning/
This episode first broadcast as a live webinar in Decmeber 2023.
Subscribe to our newsletter to hear more news, insights and events from Mtech Access.
فصل ها
1. Welcome & introductions (00:00:00)
2. Changes to specialised commissioning (00:05:20)
3. Implications for industry (00:07:20)
4. Population based budgeting (00:12:20)
5. Moving money across a pathway (00:18:56)
6. Postcode prescribing: local variation vs national variation (00:27:04)
7. What should companies be doing now around specialised commissioning? (00:38:00)
8. Who to engage with: Trusts or ICBs? (00:45:12)
9. Looking to the future - what could specialised commissioning look like in 18 months time? (00:53:14)
59 قسمت
Alle episoder
×به Player FM خوش آمدید!
Player FM در سراسر وب را برای یافتن پادکست های با کیفیت اسکن می کند تا همین الان لذت ببرید. این بهترین برنامه ی پادکست است که در اندروید، آیفون و وب کار می کند. ثبت نام کنید تا اشتراک های شما در بین دستگاه های مختلف همگام سازی شود.